ResearchPan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy
ResearchPrecision Oncology in Non-small Cell Lung Cancer: A Comparative Study of Contextualized ChatGPT Models
ResearchCombination of MDM2 and Targeted Kinase Inhibitors Results in Prolonged Tumor Control in Lung Adenocarcinomas With Oncogenic Tyrosine Kinase Drivers and MDM2 Amplification
ResearchPrioritizing Radiation and Targeted Systemic Therapies in Patients with Resected Brain Metastases from Lung Cancer Primaries with Targetable Mutations: A Report from a Multi-Site Single Institution
ResearchChemotherapy-Related Cognitive Impairment and Changes in Neural Network Dynamics: A Systematic Review
ResearchMature Type T-Lymphoblastic Leukemia/Lymphoma Presenting With Isolated Central Nervous System Symptomatology in a Patient With Giant Cell Arteritis on Long-Term Steroid Treatment
ResearchThe abscopal effect: inducing immunogenicity in the treatment of brain metastases secondary to lung cancer and melanoma
ResearchIntraoperative awake language mapping correlates to preoperative connectomics imaging: An instructive case
ResearchVepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations
ResearchNovel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling
ResearchZenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements